Both in R&D — Physical & Biological Sciences
OmniAb vs Incyte Genomics
Over the past year OABI returned +250.0% and INCY returned +19.4%; their daily moves had a correlation of 0.16.
OABI +250.0% INCY +19.4%Growth of $1, one year, split-adjusted
| Metric | OABI | INCY |
|---|---|---|
| Price | $5.18 | $122.85 |
| Market cap | $755.6M | $25.04B |
| Today | +0.58% | +4.47% |
| 1 month | +19.1% | +9.0% |
| 6 months | +262.2% | +23.0% |
| Year to date | +180.0% | +24.4% |
| 1 year | +250.0% | +21.0% |
| Revenue growth (YoY) | +78.3% | +14.0% |
| Gross margin | 92.3% | 93.0% |
| Net margin | −393.9% | −50.4% |
| P/E (TTM) | — | 62.1× |
| Price / sales | 18.8× | 4.2× |
| Net cash | $64.2M | $3.82B |
| Dividend yield | — | — |
| Volatility (60d) | 71.6% | 28.6% |
| Short % of float | 9.7% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).